Listed

Radiopharm Theranostics Ltd

RADXNasdaqCIK 1949257HealthcareFiscal year ends Jun 30

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$29.1m, FY2025
Shareholders' equity$42.9m, FY2025
Line itemUnitperiod not labelled2022-06-30period not labelled2023-06-30period not labelled2024-06-30FY20252025-06-30
Cash and equivalents$m27.0Cash and equivalents, period not labelled, at 2022-06-30$27.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure11.7Cash and equivalents, period not labelled, at 2023-06-30$11.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure18.6Cash and equivalents, period not labelled, at 2024-06-30$18.6m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure29.1Cash and equivalents, FY2025, at 2025-06-30$29.1m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure
Current assets$mnot reportednot reported22.8Current assets, period not labelled, at 2024-06-30$22.8m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure39.9Current assets, FY2025, at 2025-06-30$39.9m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure
Total assets$mnot reportednot reported72.0Total assets, period not labelled, at 2024-06-30$72.0m. XBRL concept ifrs-full:Assets. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure86.5Total assets, FY2025, at 2025-06-30$86.5m. XBRL concept ifrs-full:Assets. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure
Current liabilities$mnot reportednot reported17.6Current liabilities, period not labelled, at 2024-06-30$17.6m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure14.9Current liabilities, FY2025, at 2025-06-30$14.9m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure
Total liabilities$mnot reportednot reported44.7Total liabilities, period not labelled, at 2024-06-30$44.7m. XBRL concept ifrs-full:Liabilities. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure43.6Total liabilities, FY2025, at 2025-06-30$43.6m. XBRL concept ifrs-full:Liabilities. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure
Shareholders' equity$m63.0Shareholders' equity, period not labelled, at 2022-06-30$63.0m. XBRL concept ifrs-full:Equity. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure45.6Shareholders' equity, period not labelled, at 2023-06-30$45.6m. XBRL concept ifrs-full:Equity. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure27.4Shareholders' equity, period not labelled, at 2024-06-30$27.4m. XBRL concept ifrs-full:Equity. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure42.9Shareholders' equity, FY2025, at 2025-06-30$42.9m. XBRL concept ifrs-full:Equity. 20-F filed 2025-09-18, accession 0001213900-25-088699.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.